An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

Since the onset of the COVID-19 pandemic, the prevalence of obesity in Canada has increased at a greater rate.

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

CBSE's recent circular highlights the obesity epidemic in India, citing NFHS-5 data. With projections indicating a rise in ...

Obesity is uncommon among Hadza hunter-gatherers in Tanzania, Tsimane forager-farmers in Bolivia, Tuvan herder-farmers in Siberia, and other people in less-developed nations. But it’s widespread among ...

Hengrui Pharma and Kailera Therapeutics have reported positive topline data from the former’s Phase III trial (HRS9531-301) ...

A sweeping international study finds daily calorie burn is similar across countries — pointing to ultra-processed foods and ...

Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of ...

In 2023, 32.69 per cent of adults in Canada (10.6 million people) were overweight with a Body-Mass Index (BMI) of 30 or ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

The proportion of severely overweight children in the US has skyrocketed in recent years, with the highest rates seen in ...